NYB (NYB Holdings) Cash Conversion Cycle: 73.00 (As of Sep. 2025)


What is NYB Holdings Cash Conversion Cycle?

NYB Holdings NYB Cash Conversion Cycle is 73.00 as of Sep. 2025.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

NYB Holdings's Days Sales Outstanding for the six months ended in Sep. 2025 was 73.
NYB Holdings's Days Inventory for the six months ended in Sep. 2025 was 0.
NYB Holdings's Days Payable for the six months ended in Sep. 2025 was 0.
Therefore, NYB Holdings's Cash Conversion Cycle (CCC) for the six months ended in Sep. 2025 was 73.00.

NYB Holdings  (NAS:NYB) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.

Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.

NYB Holdings Cash Conversion Cycle Related Terms

NYB Holdings Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for NYB Holdings's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NYB Holdings Cash Conversion Cycle Chart

NYB Holdings Annual Data
Trend Sep24 Sep25
Cash Conversion Cycle
0.00 73.00

NYB Holdings Semi-Annual Data
Sep24 Sep25
Cash Conversion Cycle 0.00 73.00

NYB vs : Cash Conversion Cycle Comparison

For the Biotechnology subindustry, NYB Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NYB Holdings Cash Conversion Cycle vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NYB Holdings's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where NYB Holdings's Cash Conversion Cycle falls into.


NYB Holdings Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

NYB Holdings's Cash Conversion Cycle for the fiscal year that ended in Sep. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=73+0-0
=73.00

NYB Holdings's Cash Conversion Cycle for the quarter that ended in Sep. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=73+0-0
=73.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 73.00 mean?
NYB Holdings (NYB) has a Cash Conversion Cycle of 73.00 as of Sep. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on NYB Holdings and its competitors.
Is NYB Holdings' Cash Conversion Cycle too high?
NYB Holdings' current Cash Conversion Cycle is 73.00. The Biotechnology industry median Cash Conversion Cycle is 102.38. NYB Holdings' value of 73.00 is 28.7% below this industry median.
How does NYB Holdings' Cash Conversion Cycle compare to ?
NYB Holdings' Cash Conversion Cycle of 73.00 can be compared against companies in the Biotechnology industry. The industry median Cash Conversion Cycle is 102.38. NYB Holdings' value of 73.00 is 28.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Biotechnology company?
The median Cash Conversion Cycle among Biotechnology companies is 102.38, based on 875 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NYB Holdings's current Cash Conversion Cycle of 73.00 is 28.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on NYB Holdings and its competitors. For the Biotechnology industry, the median Cash Conversion Cycle is 102.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NYB Holdings's current Cash Conversion Cycle is 73.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NYB Holdings stock overvalued right now?
NYB Holdings (NYB) has a current Cash Conversion Cycle of 73.00. The current Cash Conversion Cycle is 73.00 and 28.7% below the Biotechnology industry median of 102.38. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For NYB Holdings (NYB), the current Cash Conversion Cycle is 73.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NYB Holdings Business Description

Comparable Companies
Address 456 Alexandra Road, No. 04-07, Fragrance Empire Building, Singapore, SGP, 119962
NYB Holdings Ltd, along with its subsidiaries, is a pre-clinical biopharmaceutical company engaged in the research and development of therapeutics and nutraceuticals derived from biodiversity, including tropical medicinal plants with a history of traditional use. It focuses on discovering and developing natural compounds for applications in oncology and other chronic diseases, and also offers a consumer nutraceutical product line.